Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Total Non-Current Liabilities: 2018-2019

  • Black Diamond Therapeutics' Total Non-Current Liabilities rose 88.85% to $4.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $4.9 million, marking a year-over-year increase of 88.85%. This contributed to the annual value of $4.9 million for FY2019, which is 88.85% up from last year.
  • According to the latest figures from Q4 2019, Black Diamond Therapeutics' Total Non-Current Liabilities is $4.9 million, which was up 88.85% from $2.6 million recorded in Q4 2018.
  • Black Diamond Therapeutics' 5-year Total Non-Current Liabilities high stood at $4.9 million for Q4 2019, and its period low was $2.6 million during Q4 2018.
  • In the last 2 years, Black Diamond Therapeutics' Total Non-Current Liabilities had a median value of $3.7 million in 2018 and averaged $3.7 million.
  • Data for Black Diamond Therapeutics' Total Non-Current Liabilities shows a peak YoY skyrocketed of 88.85% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows Black Diamond Therapeutics' Total Non-Current Liabilities stood at $2.6 million in 2018, then soared by 88.85% to $4.9 million in 2019.